Press Releases

Oct 11, 2021

New Clinical Utility Data Confirm Veracyte’s Envisia Genomic Classifier Increases Accuracy and Confidence in IPF Diagnosis

Read More

Oct 11, 2021

Veracyte Announces New Expanded Data at CHEST Underscoring Percepta Nasal Swab Test’s Ability to Improve Early Lung Cancer Assessment

Read More

Oct 06, 2021

New Data to be Presented at CHEST 2021 Showcase Clinical Performance of Veracyte’s Genomic Diagnostic Tests in Lung Cancer and Interstitial Lung Disease

Read More

Sep 14, 2021

Veracyte Announces that New NCCN Guidelines Uniquely Recommend Use of Decipher Prostate Genomic Test Score to Guide Specific Treatment for Men Following Radical Prostatectomy

Read More

Sep 01, 2021

Veracyte Further Strengthens Medical Team with Appointment of Joshua Klopper, M.D., as Medical Director of Endocrinology

Read More

Aug 31, 2021

Veracyte to Participate in Morgan Stanley 19th Annual Global Healthcare Conference

Read More

Aug 23, 2021

Veracyte Named a San Francisco Bay Area “Top Workplace” for Eighth Consecutive Year

Read More

Aug 03, 2021

Veracyte Completes Acquisition of HalioDx

Read More

Jul 29, 2021

Veracyte Announces Second Quarter 2021 Financial Results

Read More

Jul 27, 2021

New Study Suggests Decipher Prostate Biopsy Test May Help Guide Use of Active Surveillance in Prostate Cancer

Read More